genetic systems hiv 1 western blot (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
95
Structured Review
Bio-Rad
genetic systems hiv 1 western blot
Genetic Systems Hiv 1 Western Blot, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 202 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genetic+systems+hiv-1+western+blot/GS+HIV-1+Western+Blot/pmc11175659-213-1-7
Average 95 stars, based on 202 article reviews
Genetic Systems Hiv 1 Western Blot, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 202 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genetic+systems+hiv-1+western+blot/GS+HIV-1+Western+Blot/pmc11175659-213-1-7
Average 95 stars, based on 202 article reviews
genetic systems hiv 1 western blot - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
other:Article Title: The Implementation and Appraisal of a Novel Confirmatory HIV-1 Testing Algorithm in the Microbicides Development Programme 301 Trial (MDP301) Article Snippet: At CLS, serum samples were tested for HIV-1 antibodies with Abbott AxSYM HIV Ag/Ab Combo (Wiesbaden, Germany), Bio-Rad HIV-1 Genetic Systems rLAV EIA (Redmond, USA), and Article Title: Performance of the Alere Determine ™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast Article Snippet: The Article Title: A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults Article Snippet: This panel included a Bio-Rad Genetic Systems HIV 1/2 Plus O EIA (Redmond, WA, USA), Abbott Architect HIV Ab/Ag Combo EIA (Abbott Park, IL, USA), Article Title: A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults Article Snippet: All placebo recipients and Group D volunteers tested negative by ELISA (Bio-Rad Genetic Systems HIV 1/2 Plus O EIA and Abbott Architect HIV Ab/Ag Combo EIA) and Article Title: Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay Article Snippet: Reactive samples were repeated in duplicate then confirmed by the Article Title: A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults Article Snippet: If a post-enrollment ELISA was positive, additional testing was done for the participant to distinguish vaccine-induced responses from true infection, including a Article Title: False reactive HIV-1 diagnostic test results in an individual from Kenya on multiple testing platforms-A case report Article Snippet: Serology testing was performed using 4thG IA (GS HIV Combo Ag/Ab EIA), Genetic Systems HIV-1 Western blot and the Enzyme-linked Immunosorbent Assay:Article Title: Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection Article Snippet: Participants were referred with results suggestive of AHI from the community or from routine screening for AHI performed at the North Carolina (NC) State Laboratory of Public Health with Genetic Systems HIV-1/HIV-2 Plus 0 EIA, Bio-Rad Laboratories (Redmond, Washington, USA), Bio-Rad Genetic Systems HIV-1 Western Blot and Aptima HIV-1 RNA Qualitative Assay (Gen-Probe Inc., San Diego, California, USA) pooling of seronegative samples [24] until November 2013; thereafter with chemiluminescent microparticle immunoassay (CMIA) assay and the Multispot HIV-1/ HIV-2 rapid test, Bio-Rad Laboratories. .. HIV testing at enrolment was as follows: 2009 to November 2010 with Western Blot:Article Title: Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection Article Snippet: Participants were referred with results suggestive of AHI from the community or from routine screening for AHI performed at the North Carolina (NC) State Laboratory of Public Health with Genetic Systems HIV-1/HIV-2 Plus 0 EIA, Bio-Rad Laboratories (Redmond, Washington, USA), Bio-Rad Genetic Systems HIV-1 Western Blot and Aptima HIV-1 RNA Qualitative Assay (Gen-Probe Inc., San Diego, California, USA) pooling of seronegative samples [24] until November 2013; thereafter with chemiluminescent microparticle immunoassay (CMIA) assay and the Multispot HIV-1/ HIV-2 rapid test, Bio-Rad Laboratories. .. HIV testing at enrolment was as follows: 2009 to November 2010 with |
![Sensitivity of assays reactivity during early <t>HIV-1</t> infections relative to number of days before first positive WB. The names, abbreviations, and sources, of the HIV assays are as follows [4]: APTIMA HIV-1 Quantitative assay (Aptima, Gen-Probe, Inc., San Diego, CA); ARCHITECT® HIV Ag/Ab Combo assay (Architect; Abbott Diagnostics, Wiesbaden Germany; CE marked version was used as the US version was not available when testing was conducted); GS HIV-1/2 Combo Ag/Ab (BioRad Combo; Bio-Rad Laboratories, Redmond, WA); GS HIV-1/HIV-2 Plus O EIA (GS + O; Bio-Rad Laboratories, Redmond, WA); VITROS anti-HIV 1+2 assay (Vitros; Ortho-Clinical Diagnostics, Buckinghamshire, UK); ADVIA Centaur HIV 1/O/2 enhanced assay (Advia; Bayer, Tarrytown, NY); Abbott HIVAB HIV-1/HIV-2 (rDNA) EIA (Abbott; Abbott Laboratories, Abbott Park, IL); Avioq HIV-1 Microelisa system (Avioq; Avioq, Inc, Rockville, MD); Multispot HIV-1/HIV-2 rapid test (Multispot; Bio-Rad Laboratories); Clearview HIV-1/2 STAT-PAK (Statpak; Inverness Medical, Princeton, NJ); Clearview COMPLETE HIV-1/2 (Complete; Inverness Medical); Reveal G2 and G3 Rapid HIV-1 antibody tests (Reveal G2 or G3; MedMira Laboratories, Inc.; Halifax, Nova Scotia, Canada); OraQuick ADVANCE Rapid HIV-1/2 antibody test (Oraquick; OraSure Technologies, Inc.; Bethlehem, PA); Uni-Gold Recombigen HIV (Unigold; Trinity Biotech USA, St. Louis, MO). These assays have manufacturer reported point estimates for sensitivity ranging from 99.60% to 100.00% and point estimates for specificity ranging from 98.60% to 99.90%. The Genetic Systems HIV-1 Western blot (WB; Bio-Rad Laboratories) and Cambridge Biotech HIV-1 Western blot (WB; Maxim Biomedical Inc., Rockville, MD) have been shown to give concordant interpretations in studies conducted to qualify use in our clinical laboratory and were used interchangeably. ind: indeterminate.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1262/pmc11111262/pmc11111262__nihms-1994920-f0001.jpg)